XSTO Solutions and its manufacturing partner, Hamari Chemicals of Japan, have agreed to a multiyear exclusive distribution agreement for BenfoPure® brand Benfotiamine in the U.S. This follows the recent designation of self GRAS (Generally Recognized As Safe) via Hamari’s assembling of an independent panel of experts.
Xsto will utilize the new GRAS designation to introduce BenfoPure Benfotiamine to the US nutrition market as the only source of Benfotiamine with a regulatory status. BenfoPure is currently sold in Japan, Europe and other parts of the world. BenfoPure is manufactured in Japan by Hamari Chemicals, a recognized leader in nutraceutical and pharmaceutical production operating multiple facilities in Japan.
Benfotiamine is widely recognized for supporting healthy sugar metabolism, via a unique mode-of-action that reduces the negative impact of excess sugar in the diet. “Sugar consumption has soared to historically high levels and the impact on health is on the minds of consumers. We are excited to add this very timely branded ingredient from Hamari to our portfolio” stated Francis Foley, President of XSTO. “The GRAS status provides excellent opportunities for BenfoPure and we look forward to bringing this safe and beneficial ingredient to our customer base,” he added.